It has now been some time since Spark announced that they will terminate their development of

CombiGene is running the COZY pain program together with the Danish company Zyneyro with the goal

Gene therapy has the potential to transform today’s healthcare by offering treatments that actually cure severe

The GeneNova project, in which CombiGene is a part, aims to establish a common manufacturing protocol

The announcement that Spark Therapeutics is terminating the collaboration on the epilepsy project CG01 came as

In an article from May 3, 2023, Bloomberg forecasts an annualized growth of 22.8 percent for

The National Institutes of Health (NIH) is a U.S. government agency with a proud history with

At the beginning of the year, CombiGene and Zyneyro entered into a collaboration for the development

In early 2023, CombiGene and the Danish company Zyneyro initiated a collaboration to jointly develop the

It is just over four months since CombiGene began the collaboration on the pain program COZY